Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Natural Killer Cell-Based Therapies in Neuroblastoma Publisher Pubmed



Ghasempour A1 ; Mohseni R1 ; Sharif PM1 ; Hamidieh AA1
Authors

Source: Cellular Immunology Published:2025


Abstract

Neuroblastoma (NB) is the most common extracranial solid tumor of childhood forming around 15 % of all pediatric tumors. Despite advances in the treatment of NB, high-risk patients still face a grave prognosis. Adoptive cell therapies based on NK cells are becoming an assistive treatment for such cases. Moreover, there is also evidence that NKT-based therapies have promising results in the management of NB. Lower complications in comparison with adoptive T cell therapies, various cell sources, and miscellaneous tumor recognition mechanisms are some of the advantages of NK- and NKT-based therapies. This review is dedicated to searching for recent advances in this field. © 2024 Elsevier Inc.
1. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)
Experts (# of related papers)
Other Related Docs
15. Car-Nk Cells: A Promising Cellular Immunotherapy in Lymphoma, Expert Opinion on Biological Therapy (2023)
17. Advances in Pharmacotherapy for Neuroblastoma, Expert Opinion on Pharmacotherapy (2021)
20. Tumor Immunology, Clinical Immunology (2022)